1. Home
  2. Ready for consensus on NSG, opposed to U.N. ban on Azhar: China

Ready for consensus on NSG, opposed to U.N. ban on Azhar: China

[email protected] (Agencies)
October 10, 2016

Beijing, Oct 10: Ahead of President Xi Jinping's visit to India, China on Monday said it is “ready” for talks with India on its entry into the NSG but defended extending a hold on India's bid for a U.N. ban on JeM chief Masood Azhar, saying Beijing is opposed to anyone making “political gains in the name of counter-terrorism.”

maBriefing media in Beijing on Mr. Xi's visit to India this week to take part in the BRICS Summit in Goa, China's Vice Foreign Minister Li Baodong again harped on the need to build consensus over the admission of new members in the 48-member Nuclear Suppliers Group (NSG).

Asked if any progress on the issue of India's admission into NSG can be expected in the meeting between Mr. Xi and Prime Minister Narendra Modi on the sidelines of the BRICS Summit, Mr. Li said NSG rules stipulate consensus among the members to admit new ones.

“These rules are not to be decided by China alone. On the issue, China and India have maintained good communication and we are ready to continue consultations with India to build consensus and we also hope India can go to other members of the NSG as well,” Mr. Li said replying to a question on China's reservations on India's admission to the elite nuclear trading club.

“In this aspect we are also ready for discussions with India to explore possibilities but things need to be in keeping up with procedures, norms and regulations of the NSG. On this issue, China position is consistent. That is why China has often said international law must be observed,” he said.

Mr. Xi will travel to Goa to attend the BRICS Summit scheduled to held between October 15 and16. The BRICS grouping consists of Brazil, Russia, India, China, South Africa.

While India has blamed one country, without naming China, for stalling its membership in the NSG, both the countries held talks recently to iron out differences.

After talks with India, China also has held similar talks with Pakistan, which also applied for membership in the influential grouping.

Replying to a question on criticism about China's move to stall India's bid for a U.N. ban on Azhar — head of Pakistan-based terrorist group Jaish-e-Muhammad, Mr. Li sought to justify Beijing's recent technical hold in the matter, saying, “China is opposed to all forms of terrorism.”

“There should be no double standards on counter- terrorism. Nor should one pursue own political gains in the name of counter-terrorism,” he said in a veiled reference to India, which is pressing for the U.N. ban against Azhar over his role in the Pathankot terror attack.

China had announced the extension of its “technical hold” on India's bid to get Azhar designated as a terrorist by the U.N. on October 1, 2016, days before it was to expire. The hold can continue for upto three months more.

During Monday's briefing, Mr. Li said counter-terrorism cooperation will figure in the BRICS Summit.

“On counter-terrorism, it is an important area for cooperation among BRICS members for political security. Cooperation on this front will enhance BRICS communication and coordination and will contribute to world peace and security. That is quite obvious,” he said.

He said BRICS Foreign Ministers reached agreement on counter-terrorism during their meeting on the margins of the U.N. General Assembly last month.

“We hope and believe that this Goa summit will build on the past consensus and continue to strengthen cooperation in counter-terrorism and other issues of political security and contribute to world peace and security,” he said.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 6,2020

Seoul, Jun 6: South Korea on Saturday reported 51 new cases of COVID-19, mostly in the densely populated capital region, as authorities scramble to stem transmissions among low-income workers who can't afford to stay home.

The figures announced by South Korea's Centers for Disease Control and Prevention brought national totals to 11,719 workers and 273 deaths.

At least 34 of the new coronavirus cases were linked to door-to-door sellers hired by Richway, a Seoul-based health product provider.

Vice Health Minister Kim Gang-lip said the spread of the virus among Richway sellers was particularly alarming as most of them are in their 60s and 70s. He called for officials to strengthen their efforts to find and examine workplaces vulnerable to infections.

More than 120 infections have also been linked to a massive warehouse operated by Coupang, a local e-commerce giant, which has been accused of failing to properly implement preventive measures and having employees work even when sick.

South Korea was reporting around 500 new cases per day in early March due to a massive outbreak surrounding the southern city of Daegu, before officials managed to stabilize the situation with aggressive tracking and testing.

But the recent resurgence of COVID-19 in the greater capital area, where about half of South Korea's 51 million people live, is now threatening to erase some of the country's hard-won gains. It has also led to second-guessing whether officials were too quick to ease social distancing and reopen schools.

Health authorities and hospital officials on Friday participated in a table-top exercise for sharing hospital capacities between Seoul and nearby cities and ensure swift transports of patients so that a spike of cases in one area doesn't overwhelm its hospital system. 

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 5,2020

Ninety per cent of a sample group of coronavirus-recovered patients from a prominent hospital in China's Wuhan city where the pandemic broke out have reported lung damage and five per cent of them are again in quarantine after testing positive for the virus, according to a media report on Wednesday.

A team at the Zhongnan Hospital of Wuhan University led by Peng Zhiyong, director of the hospital's Intensive Care Unit, has been conducting follow-up visits with '100 recovered patients' since April.

The first phase of this one-year programme finished in July. The average age of the patients in the study is 59.

According to the first phase results, 90 per cent of the patients' lungs are still in a damaged state, which means their lungs ventilation and gas exchange functions have not recovered to the level of healthy people, state-run Global Times reported.

Peng's team conducted a six-minute walking test with the patients. They found that the recovered patients could only walk 400 metres in six minutes while their healthy peers could walk 500 metres in the same period.

Some recovered patients have to rely on oxygen machines even three months after being discharged from the hospital, Liang Tengxiao, a doctor from the Dongzhimen Hospital, Beijing University of Chinese Medicine, was quoted as saying by the report.

Liang's team is also conducting follow-up visits with recovered patients aged above 65.

The results also showed that antibodies against the novel coronavirus in 10 per cent of the 100 patients have disappeared.

Five per cent of them received negative results in Covid-19 nucleic acid tests but positive results in Immunoglobulin M (IgM) tests, and thus have to be quarantined again, the report said.

IgM is usually the first antibody produced by the immune system when a virus attacks. A positive result in an IgM test usually means that a person has just been infected by the virus.

It is still unclear if this means these people have been infected again.

The 100 patients' immune systems have not fully recovered as they showed a low level of B cells -- - a primary force for killing viruses in the human body -- but a high level of T cells which only recognise viral antigens outside infected cells.

"The results revealed that the patients’ immune systems are still recovering," Peng said.

The patients also suffered from depression and a sense of stigma. Most of the recovered patients told the team that their families were not willing to have dinner with them at the same table, the report said.

Less than half of the recovered patients have returned to work, it said.

The findings are significant as the coronavirus first emerged in Wuhan city.

Hubei province for which Wuhan is the provincial capital has reported a total of 68,138 confirmed Covid-19 cases till now. The disease has claimed 4,512 lives in the province, according to the official data.

China reported 27 new confirmed Covid-19 cases on Tuesday, including 22 locally-transmitted cases, the National Health Commission (NHC) said on Wednesday.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Paris, Apr 10: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could be a potential weapon against novel coronavirus, across 50 countries.

The company has already doubled its incremental production capacity on top of the usual production for current indications across its eight hydroxychloroquine manufacturing sites worldwide and is on track to quadruple it by the summer.

"In this global health emergency, Sanofi stands ready to assist as many countries as possible, starting with countries where its medicine is registered for current approved indications as well as countries where there are no hydroxychloroquine suppliers or countries with underserved populations," it said in a statement.

Sanofi called for coordination among the entire hydroxychloroquine chain worldwide to ensure the continued supply of the medicine if proven to be a well-tolerated and effective treatment in COVID-19 patients.

"The COVID-19 pandemic is an unprecedented health and economic crisis which is shaking some of the very fundamentals of international solidarity and cooperation among countries," said Chief Executive Officer Paul Hudson. "This virus does not care about the concept of borders, so we should not either," he added.

"It is critical that international authorities, local governments, manufacturers and all other players involved in the hydroxychloroquine chain work together in a coordinated manner to ensure all patients who may benefit from this potential treatment can access it. If the trials prove positive, we hope our donation will play a critical role for patients," said Hudson.

While hydroxychloroquine is generating a lot of hope for patients around the world, said Sanofi, it should be remembered that there are no results from ongoing studies and the results may be positive or negative.

To date, there is insufficient clinical evidence to draw any conclusion over the safety and efficacy of hydroxychloroquine in the management of COVID-19 patients.

It is one of several medicines being investigated by the World Health Organisation (WHO) in its international clinical trial seeking a treatment solution for COVID-19. "Sanofi is supporting ongoing trials by providing the medicine to some participating investigator sites and other independent research centres," it said.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.